ストックスクリーナーアプリを入手
13.66
5.77%
0.745
アフターアワーズ：
13.64
-0.025
-0.18%
前日終値:
$12.92
開ける：
$13.03
24時間の取引高:
28,215
Relative Volume:
0.99
時価総額：
$27.97M
収益：
-
当期純損益:
$-4.85M
株価収益率:
-44.08
EPS:
-0.31
ネットキャッシュフロー:
$-3.95M
1週間 パフォーマンス:
-3.32%
1か月 パフォーマンス:
-1.19%
6か月 パフォーマンス:
-16.78%
1年 パフォーマンス:
-19.43%
1日の値動き範囲:
$12.77
$13.75
1週間の範囲:
$12.71
$14.18
52週間の値動き範囲:
$8.74
$22.90
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
CVKD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CVKD
Cadrenal Therapeutics Inc
|
13.66 | 26.45M | 0 | -4.85M | -3.95M | -0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-12-18 | 開始されました | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc (CVKD) 最新ニュース
Applying Elliott Wave Theory to Cadrenal Therapeutics Inc.July 2025 WrapUp & Fast Gain Stock Tips - newser.com
Quantitative breakdown of Cadrenal Therapeutics Inc. recent moveTrade Risk Summary & Safe Entry Momentum Tips - newser.com
Measuring Cadrenal Therapeutics Inc.’s beta against major indicesQuarterly Trade Report & Reliable Momentum Entry Alerts - newser.com
Price momentum metrics for Cadrenal Therapeutics Inc. explainedJuly 2025 Setups & Free Accurate Trade Setup Notifications - newser.com
What to do if you’re stuck in Cadrenal Therapeutics Inc.July 2025 PreEarnings & Scalable Portfolio Growth Ideas - newser.com
What institutional flow reveals about Cadrenal Therapeutics Inc.Trend Reversal & Stepwise Swing Trade Plans - newser.com
Cadrenal Therapeutics Inc Stock Analysis and ForecastEarnings Beat Highlights & The Best Picks Hiding in Plain Sight - earlytimes.in
Is Cadrenal Therapeutics Inc. trending in predictive chart modelsWeekly Market Outlook & Weekly Market Pulse Updates - newser.com
Applying chart zones and confluence areas to Cadrenal Therapeutics Inc.Weekly Investment Recap & Fast Gain Stock Trading Tips - newser.com
Is Cadrenal Therapeutics Inc. stock a good choice for value investors2025 Volatility Report & Verified Entry Point Detection - newser.com
Kuick Research Releases Landmark Study On US Orphan Drug Rare Disease Market Highlighting Investment And Innovation Opportunities Through 2030 - Benzinga
Combining machine learning predictions for Cadrenal Therapeutics Inc.July 2025 Weekly Recap & Accurate Buy Signal Notifications - newser.com
Is Cadrenal Therapeutics Inc. stock cheap compared to fundamentals2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com
Viridian Therapeutics (NASDAQ:VRDN) Director Acquires $9,999,990.00 in Stock - Defense World
Will Cadrenal Therapeutics Inc. see short term momentumQuarterly Earnings Summary & Long-Term Capital Growth Ideas - newser.com
Why Cadrenal Therapeutics Inc. stock is rated strong buy2025 Earnings Impact & Fast Moving Trade Plans - newser.com
Insider Sell: Matthew Szot Sells Shares of Cadrenal Therapeutics Inc (CVKD) - GuruFocus
Cadrenal Therapeutics Executives Sell Shares - TradingView
CVKD CFO reports 3,600-share sale; 9,933 shares remain - Stock Titan
CVKD insider Quang Pham reports sales under Rule 10b5‑1 plan - Stock Titan
Can Cadrenal Therapeutics Inc. stock reach $100 price target2025 Trading Recap & Fast Entry Momentum Trade Alerts - fcp.pa.gov.br
History Review: Will Cadrenal Therapeutics Inc. stock outperform value stocksJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - Fundação Cultural do Pará
Aug Update: Can Cadrenal Therapeutics Inc. stock outperform in 2025 bull marketMarket Activity Summary & Weekly High Potential Stock Alerts - fcp.pa.gov.br
Price Action: How rising interest rates impact Cadrenal Therapeutics Inc. stock2025 Market WrapUp & Long Hold Capital Preservation Tips - fcp.pa.gov.br
Can Cadrenal Therapeutics Inc. stock outperform in 2025 bull marketWeekly Trend Recap & Proven Capital Preservation Tips - Fundação Cultural do Pará
Cadrenal Therapeutics Inc (CVKD) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):